Cargando…
The Role of Immune Correlates and Surrogate Markers in the Development of Vaccines and Immunotherapies for Plague
One of the difficulties in developing countermeasures to biothreat agents is the challenge inherent in demonstrating their efficacy in man. Since the first publication of the Animal Rule by the FDA, there has been increased discussion of potential correlates of protection in animal models and their...
Autor principal: | Williamson, E. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182760/ https://www.ncbi.nlm.nih.gov/pubmed/21991451 http://dx.doi.org/10.1155/2012/365980 |
Ejemplares similares
-
Plague vaccines: current developments and future perspectives
por: Feodorova, Valentina A, et al.
Publicado: (2012) -
Plague vaccines: new developments in an ongoing search
por: Rosenzweig, Jason A., et al.
Publicado: (2021) -
Anti-Plague Vaccine in the Treatment of Plague
por: Naidu, T. S.
Publicado: (1930) -
Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003) -
Leishmania Immunity: Advancing Immunotherapy and Vaccine Development
por: Ikeogu, Nnamdi M., et al.
Publicado: (2020)